Saturday, December 1, 2018

Sebi starts probe against Sun Pharma, to also reopen insider trading case

The whistle-blower accused the company of committing corporate governance and tax-related lapses, besides other securities market-related violations

from Latest News https://ift.tt/2rgpe1c
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

Related Posts:

0 comments: